59 developer-"https:" "https:" "https:" "Universidade do Minho CTAC" positions at VIB
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
of the Directors’ Office. Responsibilities Governance & decision-making support Coordinate and manage the institute’s governance calendar, ensuring timely and well-prepared decision-making; Prepare agendas, collect
-
leading research institute focused on understanding cancer biology and developing innovative therapies. Our Bioinformatics & AI Expertise Unit provides advanced computational support to multiple research
-
, concepts, formats, scripts, visuals, subtitles, and workflow. You experiment (and learn) with tools to produce faster and better, without losing the brand style. Content planning and monitoring You develop
-
connected within the European network of peer facilities. https://agro-incubator.sites.vib.be/ https://vib.be/ About the role We are seeking an inspiring and strategic Head of the VIB Agro-Incubator to lead
-
We are looking for a highly motivated PhD student to join the Nucleic Acid Immunity Lab at the VIB-UGent Center for Inflammation Research. Lab website: https://www.irc.ugent.be/groups/maelfait-lab
-
centrosome is essential for early embryonic cell divisions, we still do not understand the profound “centrosome reduction” it undergoes during spermatogenesis and how this pathway impacts embryo development
-
for Neuroscience . The Verstreken lab is developing advanced multielectrode array systems to mimic human brain circuits relevant to neurodegenerative disease. They are also conducting advanced CRISPR screens
-
antibody specificity profiling. KEY RESPONSIBILITIES You’ll join a small team advancing a new screening platform focused on therapeutic antibody specificity. The aim is to deploy this newly developed assay
-
an innovative, challenging and international working environment in the large life-sciences network of VIB. We offer opportunities for personal development. Taking additional training and courses is
-
supported by a Foundation against Cancer (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in tumor-associated macrophages (TAMs) in vivo. We